PMGC HOLDINGS INC. Stock-Based Compensation
PMGC HOLDINGS INC. (ELAB) reported Stock-Based Compensation of $182.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $174.54K, a 1001.79% increase year-over-year.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $8.22K.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $10.66K, a 73.12% decline year-over-year.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $13.18K, a 71.98% decline year-over-year.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2025 was -$19.16K, a 119.72% decline from fiscal 2024.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $97.17K, a 80.08% decline from fiscal 2023.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $487.74K, a 183.78% increase from fiscal 2022.
- PMGC HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $171.87K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $174.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $182.76K 10-Q · filed 2026-08-14 | $193.42K derived: sum of 3 quarters · filed 2026-08-14 | $206.60K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $8.22K 10-Q · filed 2026-05-15 | $18.87K derived: sum of 2 quarters · filed 2026-05-15 | $32.05K derived: sum of 3 quarters · filed 2026-05-15 | $47.89K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $10.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.84K derived: sum of 2 quarters · filed 2026-03-30 | $39.68K derived: sum of 3 quarters · filed 2026-08-14 | -$19.16K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $13.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $29.02K derived: sum of 2 quarters · filed 2026-08-14 | -$29.82K 10-Q · filed 2025-11-14 | $9.83K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $15.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$43.00K 10-Q · filed 2026-08-14 | -$3.35K derived: sum of 3 quarters · filed 2026-08-14 | $43.69K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$58.84K 10-Q · filed 2026-05-15 | -$19.19K derived: sum of 2 quarters · filed 2026-05-15 | $27.84K derived: sum of 3 quarters · filed 2026-05-15 | -$17.01K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $39.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $86.68K derived: sum of 2 quarters · filed 2026-03-30 | $41.83K derived: sum of 3 quarters · filed 2026-03-30 | $97.17K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $47.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.18K derived: sum of 2 quarters · filed 2025-11-14 | $57.52K 10-Q · filed 2025-11-14 | $198.71K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$44.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.48K 10-Q · filed 2025-08-13 | $151.67K derived: sum of 3 quarters · filed 2025-08-13 | $313.15K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $55.34K 10-Q · filed 2025-05-14 | $196.53K derived: sum of 2 quarters · filed 2025-05-14 | $358.01K derived: sum of 3 quarters · filed 2025-05-14 | $467.92K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $141.19K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $302.67K derived: sum of 2 quarters · filed 2025-03-28 | $412.58K derived: sum of 3 quarters · filed 2025-03-28 | $487.74K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $161.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $271.39K derived: sum of 2 quarters · filed 2024-11-14 | $346.55K 10-Q · filed 2024-11-14 | $346.55M 10-Q · filed 2023-12-11 | -$93.58M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $109.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $185.07K 10-Q · filed 2024-08-14 | -$93.74M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $75.16K 10-Q · filed 2024-05-15 | -$93.85M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$93.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $171.87K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $94.10M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |